Merxin is active in the fields of pharmaceuticals and cannabinoid therapies (inhaled cannabinoid therapies iCTx).
MRX002+ is a see-through pMDI vial designed for low carbon footprint propellant formulations.
MRX002+ enables carbon neutral inhalers.
MRX002+ has been designed to be compatible with HFA 152a and...
EXPLORE MRX002+
MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.
It is developed for new molecules and the...
EXPLORE MRX003
MRX004 is a soft mist inhaler device. It is developed as an interchangeable AB rated device opportunity for tiotropium/olodaterol as formulated with the Respimat.
MRX004 is...
EXPLORE MRX004
Dual cavity for triple therapy dry powder inhaler (DPI). MRX006 is based on the open-inhale-close principle. It is suitable as an AB-rated substitutable device for triple combination...
EXPLORE MRX006